Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Similar documents
Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Mahindra & Mahindra Ltd.

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Amber Enterprises India Ltd

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Hindustan Media Ventures

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Procter & Gamble Hygiene & Health Care

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Mahindra & Mahindra Ltd.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Century Plyboards Ltd

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Transport Corporation of India

Apollo Micro Systems Ltd

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Varroc Engineering Ltd.

Future Supply Chain Solutions Ltd

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Newgen Software Technologies Ltd

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

MISHRA DHATU NIGAM Ltd.

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Avenue Supermarts Limited

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Navkar Corporation BUY. Performance Update. CMP Target Price `175 `265. 2QFY2017 Result Update Logistics. Historical share price chart.

Tata Consultancy Services (TCS)

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Navkar Corporation BUY. Performance Update. CMP Target Price `200 `265. 4QFY2016 Result Update Logistics. Historical share price chart

Bajaj Auto ACCUMULATE. Performance Highlights. CMP `2,815 Target Price `3,151. 1QFY2018 Result Update Automobile. 24 July 2017

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

NEUTRAL. Neogen Chemicals Ltd. Issue Open: April 24, 2019 Issue Close: April 26, IPO Note Specialty Chemicals

Aster DM Healthcare Ltd

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Dr. Reddy s Laboratories

Simplex Infrastructures

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Safari Industries BUY. On a fast paced Safari. Initiating Coverage Luggage February 21, CMP Target Price `532 ` year daily price chart

Sandhar Technologies Limited

Transcription:

Nov-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Footwear November 3, 2018 Bata India Performance Update Y/E March (` cr) 2QFY19 2QFY18 % yoy 1QFY19 % qoq Net sales 673 587 14.7 797 (15.6) EBITDA 87 64 35.5 132 (33.7) EBITDA margin (%) 13.0 11.0 199bp 16.5 (356bp) Adjusted PAT 56 43 29.8 83 (32.6) Source: Company, Angel Research For 2QFY2019, Bata India (BIL) posted strong set of numbers, exceeding our expectations on bottom-line front. Revenues grew by ~15% yoy (in-line with our estimate). The company s operating margins improvement by robust 199bps yoy. On the bottom-line front, BIL reported growth of ~30% yoy to `56cr on the back of strong operating performance. Healthy volume growth drives top-line: BIL s top-line grew by ~15% yoy to `673cr on the back of healthy growth in footwear segment. The growth was mainly due to successful new brand campaign 'Be Surprised' featuring Kriti Sanon, the stylish Bollywood actor and youth icon as the new face for Bata's fashion forward women's range and over 100 new styles. Bata India continued the launch of its international 'Red Angela' stores in multiple cities across India. With almost 50 new international design 'Red Angela' stores now open, it has already started to yield positive results by way of footfalls and delighted customers. Strong operating performance aids profitability: On the operating front, the company reported better margins, up 199bps yoy at 13.0%. On the bottom-line front, BIL reported growth of ~30% yoy to `56cr on the back of strong operating performance and healthy top-line growth. BUY CMP `1,008 Target Price `1,243 Investment Period 12 months Sector Market Cap (Rs cr) Footwear 12,951 Net Debt (591) Beta 0.9 52 Week High / Low 1,116/657 Avg. Daily Volume 179,938 Face Value (Rs) 5 BSE Sensex 35,012 Nifty 10,553 Reuters Code BATA.BO Bloomberg Code BATA.IN Shareholding Pattern (%) Promoters 53.0 MF / Banks / Indian Fls 16.0 FII / NRIs / OCBs 8.8 Indian Public / Others 22.2 Abs. (%) 3m 1yr 3yr Sensex (5.8) 4.3 31.8 BIL 3.8 23.8 100.0 Historical share price chart 1,200 Outlook and Valuation: We expect BIL to report net revenue CAGR of ~15% to ~`3,494cr over FY2018-20E mainly due to increasing brand consciousness among Indian consumers, new product launches, higher number of store additions in tier II/ III cities and focus on high growth women s segment. Further, on the bottom-line front, we expect CAGR of ~22% to `329cr over the same period on the back of margin improvement (increasing premium product sales). Thus, we maintain our Buy recommendation on Bata India with Target Price of `1,243. 1,000 800 600 400 200 0 Key Financials Y/E March (` cr) FY2017 FY2018 FY2019E FY2020E Net sales 2,474 2,634 3,006 3,494 % chg 2.1 6.5 14.1 16.2 Adj. Net profit 173 221 280 329 % chg 3.9 27.7 27.0 17.4 EBITDA margin (%) 10.4 13.3 14.5 14.7 EPS (`) 13.4 17.2 21.8 25.6 P/E (x) 75.0 58.7 46.3 39.4 P/BV (x) 9.8 8.7 7.6 6.5 RoE (%) 13.0 14.8 16.3 16.6 RoCE (%) 14.5 19.5 21.4 22.0 EV/Sales (x) 5.0 4.7 4.1 3.5 EV/EBITDA (x) 48.4 35.2 28.1 23.6 Source: Company, Angel Research Note Source: Company, Angel Research Research Analyst Amarjeet S Maurya 022-40003600 Ext: 6831 amarjeet.maurya@angelbroking.com Please refer to important disclosures at the end of this report 1

Exhibit 1: 2QFY2019 Performance Y/E March (` cr) 2QFY19 2QFY18 % yoy 1QFY19 % qoq 1HFY19 1HFY18 % chg Net Sales 673 587 14.7 797 (15.6) 1470 1330 10.6 Consumption of RM 298 263 13.0 373 (20.1) 670 621 7.9 (% of Sales) 44.2 44.9 46.7 45.6 46.7 Staff Costs 81 71 13.9 82 (1.7) 163 145 12.4 (% of Sales) 12.0 12.1 10.3 11.1 10.9 Selling & Adm Expenses 94 100 (5.5) 91 3.7 185 183 1.4 (% of Sales) 14.0 17.0 11.4 12.6 13.8 Other Expenses 113 88 28.0 120 (5.6) 232 221 5.2 (% of Sales) 16.8 15.0 15.0 15.8 16.6 Total Expenditure 586 522 12.1 665 (12.0) 1,251 1,170 6.9 Operating Profit 87 64 35.5 132 (33.7) 219 160 37.0 OPM 13.0 11.0 16.5 14.9 12.0 Interest 1 1 46.4 1 25.4 2 2 22.0 Depreciation 15 14 6.5 15 2.2 30 28 7.9 Other Income 15 15 0.5 12 24.3 27 26 1.8 PBT (excl. Ext Items) 86 64 33.8 128 (32.9) 214 157 36.4 Ext (Income)/Expense - - - - - PBT (incl. Ext Items) 86 64 33.8 128 (32.9) 214 157 36.4 (% of Sales) 12.7 10.9 16.0 14.5 11.8 Provision for Taxation 30 21 41.9 45 (33.6) 75 53 41.6 (% of PBT) 35.1 33.1 35.4 35.3 34.0 Reported PAT 56 43 29.8 83 (32.6) 138 103 33.8 PATM 8.3 7.3 10.4 9.4 7.8 Minority Interest After NP Reported PAT 56 43 29.8 83 (32.6) 138 103 33.8 Extra-ordinary Items Adj PAT 56 43 29.8 83 (32.6) 138 103 33.8 Equity shares (cr) 13 13 13 13 13 FDEPS (`) 4.3 3.3 29.8 6.4 (32.6) 10.8 8.0 33.8 Source: Company, Angel Research November 3, 2018 2

Outlook and Valuation We expect BIL to report net revenue CAGR of ~15% to ~`3,494cr over FY2018-20E mainly due to increasing brand consciousness among Indian consumers, new product launches, higher number of store additions in tier II/ III cities and focus on high growth women s segment. Further, on the bottom-line front, we expect CAGR of ~22% to `329cr over the same period on the back of margin improvement (increasing premium product sales). Thus, we maintain our Buy recommendation on Bata India with Target Price of `1,243. Downside risks to our estimates Store expansion from competitors like Khadim and Relaxo could impact the company s sales growth Slowdown in economy could hurt the overall profitability of the company Company Background BATA India Ltd (BIL) is the largest footwear retailer in India, offering footwear and accessories & bags across brands like Bata, Hush Puppies, Naturalizer, Power, Marie Claire, Weinbrenner, North Star, Scholl, Bata Comfit and Bubblegummers. Currently, the company s ~70% revenue is derived from Men & Kids footwear segment and balance from women s segment. BIL retails in over 1,290 Bata stores on bata.in and has thousands of multi-brand footwear dealer stores pan-india. November 3, 2018 3

Profit & Loss Statement Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E Net Sales 2,423 2,474 2,634 3,006 3,494 % chg (10.1) 2.1 6.5 14.1 16.2 Total Expenditure 2,147 2,217 2,283 2,570 2,980 Raw Material 1,152 1,158 1,202 1,371 1,607 Personnel 261 273 296 343 405 Selling & Adm 345 356 362 436 507 Others Expenses 389 430 423 421 461 EBITDA 276 257 351 436 514 % chg (17.3) (6.8) 36.8 24.0 17.8 (% of Net Sales) 11.4 10.4 13.3 14.5 14.7 Depreciation& Amortisation 79 65 60 69 79 EBIT 197 192 291 367 435 % chg (22.5) (2.6) 51.6 26.2 18.5 (% of Net Sales) 8.1 7.8 11.0 12.2 12.5 Interest & other Charges 2 4 4 4 4 Other Income 101 46 50 55 60 (% of PBT) 34.2 19.7 14.9 13.2 12.2 Recurring PBT 297 234 337 418 491 % chg (9.8) (21.1) 44.1 24.0 17.4 Tax 79 75 117 138 162 (% of PBT) 26.7 32.0 34.6 33.0 33.0 PAT (reported) 217 159 221 280 329 Extraordinary Items 51 (14) - - - ADJ. PAT 166 173 221 280 329 % chg (20.5) 3.9 27.7 27.0 17.4 (% of Net Sales) 6.9 7.0 8.4 9.3 9.4 Basic EPS (`) 12.9 13.4 17.2 21.8 25.6 Fully Diluted EPS (`) 12.9 13.4 17.2 21.8 25.6 % chg (20.5) 3.9 27.7 27.0 17.4 November 3, 2018 4

Balance Sheet Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E SOURCES OF FUNDS Equity Share Capital 64 64 64 64 64 Reserves& Surplus 1,157 1,260 1,429 1,651 1,916 Shareholders Funds 1,221 1,324 1,493 1,716 1,980 Total Loans - - - - - Deferred Tax Liability - - - - - Total Liabilities 1,221 1,324 1,493 1,716 1,980 APPLICATION OF FUNDS Gross Block 382 406 508 578 678 Less: Acc. Depreciation 78 138 199 267 346 Net Block 304 268 309 311 332 Capital Work-in-Progress 19 30 - - - Investments - - - - - Current Assets 1,321 1,525 1,680 1,975 2,322 Inventories 685 714 765 881 1,034 Sundry Debtors 71 69 89 107 134 Cash 342 522 591 704 812 Loans & Advances 59 57 61 78 98 Other Assets 163 163 174 204 245 Current liabilities 512 599 597 670 775 Net Current Assets 809 926 1,084 1,304 1,547 Deferred Tax Asset 89 100 100 100 100 Mis. Exp. not written off - - - - - Total Assets 1,221 1,324 1,493 1,716 1,980 November 3, 2018 5

Consolidated Cashflow Statement Y/E March (` cr) FY2016 FY2017 FY2018 FY2019E FY2020E Profit before tax 297 234 337 418 491 Depreciation 79 65 60 69 79 Change in Working Capital (41) 53 (88) (108) (135) Interest / Dividend (Net) (24) (40) 4 4 4 Direct taxes paid (108) (65) (117) (138) (162) Others 1 10 0 0 0 Cash Flow from Operations 204 257 197 245 276 (Inc.)/ Dec. in Fixed Assets (39) (48) (72) (70) (100) (Inc.)/ Dec. in Investments (75) (181) 0 0 0 Cash Flow from Investing (114) (229) (72) (70) (100) Issue of Equity 0 0 0 0 0 Inc./(Dec.) in loans 0 0 0 0 0 Dividend Paid (Incl. Tax) (42) (45) (51) (58) (64) Interest / Dividend (Net) 85 197 (4) (4) (4) Cash Flow from Financing 43 152 (56) (62) (68) Inc./(Dec.) in Cash 132 180 69 113 108 Opening Cash balances 210 342 522 591 704 Closing Cash balances 342 522 591 704 812 November 3, 2018 6

Key Ratio Y/E March FY2016 FY2017 FY2018 FY2019E FY2020E Valuation Ratio (x) P/E (on FDEPS) 77.9 75.0 58.7 46.3 39.4 P/CEPS 43.7 57.8 46.1 37.2 31.8 P/BV 10.6 9.8 8.7 7.6 6.5 Dividend yield (%) 0.3 0.3 0.4 0.4 0.5 EV/Sales 5.2 5.0 4.7 4.1 3.5 EV/EBITDA 45.7 48.4 35.2 28.1 23.6 EV / Total Assets 10.3 9.4 8.3 7.1 6.1 Per Share Data ((`) EPS (Basic) 12.9 13.4 17.2 21.8 25.6 EPS (fully diluted) 12.9 13.4 17.2 21.8 25.6 Cash EPS 23.0 17.4 21.9 27.1 31.7 DPS 3.5 3.5 4.0 4.5 5.0 Book Value 95.0 103.0 116.2 133.5 154.1 Returns (%) ROCE 16.1 14.5 19.5 21.4 22.0 Angel ROIC (Pre-tax) 22.4 23.9 32.2 36.3 37.2 ROE 13.6 13.0 14.8 16.3 16.6 Turnover ratios (x) Asset Turnover (Gross Block) 6.3 6.1 5.2 5.2 5.2 Inventory / Sales (days) 103 105 106 107 108 Receivables (days) 11 10 12 13 14 Payables (days) 51 62 57 56 56 Working capital cycle (ex-cash) (days) 63 54 61 64 66 November 3, 2018 7

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement Bata India 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Returns): Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) Reduce (-5% to -15%) Sell (< -15%) November 3, 2018 8